Carbon transformation company Twelve and biotechnology company LanzaTech have partnered to transform CO2 emissions into polypropylene, a key polymer used for medical devices including syringes and IV bags, as well as for large-scale applications in automotive, furniture, textiles and other everyday products.
Twelve’s carbon transformation technology converts CO2 into materials that are traditionally made from fossil fuels. The company helps brands eliminate emissions by replacing the petrochemicals in their products and supply chains with CO2Made® carbon negative chemicals and materials, as well as carbon neutral fuels.
LanzaTech’s carbon recycling Pollution To Products™ technology uses nature-based solutions to produce ethanol and other materials from waste carbon sources. The partnership will bring together the two platform technologies to enable additional product development from CO2 streams, representing just one of many pathways to scale carbon transformation solutions.
Read the full story at ESG Today.
Beauty and consumer products companies Unilever, Henkel, L’Oréal, LVMH and Natura &Co announced today a new collaboration to develop an environmental impact assessment and scoring system for cosmetic products.
Aimed at meeting growing consumer demand for transparency into the impact of products, the new system will provide clear and comparable information across the product lifecycle, providing an overall environmental impact score and enabling comparisons across cosmetics products within the same category.
At Bachem, we are committed to sustainability by taking responsibility towards our employees, the society, and the environment. We aim to redesign our processes to minimize the use and generation of hazardous substances, and reduce the environmental impact. In the pharmaceutical industry, solvent consumption generates a significant environmental footprint. Research is conducted to decrease solvent volumes or for substituting them by environmentally benign solvents. Both represents an impactful innovation in API production processes. We are a leading company in the development and manufacture of peptide and oligonucleotide APIs. In peptide manufacturing, our most important technology and core expertise is the solid-phase peptide synthesis (SPPS), a well-established method for peptide production.
In the attempt to make the SPPS a greener technology, we conducted, in collaboration with our partner Novo Nordisk, two studies to propose solvent alternatives to replace the reprotoxic N,N-dimethylformamide (DMF), dichloromethane (DCM) and N-methyl-2-pyrrolidone (NMP). These solvents are the gold standards in SPPS processes for academic research and industrial production facilities alike. They have excellent solubilization and stability properties for reagents and are the best choice in terms of resin swelling. Yet they are to be restricted by the European Chemicals Agency (ECHA) due to their hazardous nature. Replacing DMF, DCM and NMP for a greener alternative represents a huge challenge, but a great improvement towards reduced environmental footprint processes.
Read the full story at European Pharmaceutical Manufacturer.
Jay McHarg, CEO of AeroSafe Global, discusses the importance of a sustainable, eco-friendly supply chain, how it’s critical for pharmaceutical companies and how it can play a role in delivering better outcomes for both patients and the environment.
Read the full story at Chemical & Engineering News.
The enzyme development start-up Arzeda has landed a partnership with the consumer goods giant Unilever to develop enzymes for household cleaning applications.
Many dish detergents and hard surface cleaners already use enzymes, which can break down soils, oils, and other grime as well as boost the performance of other ingredients. Enzymes, along with live microbes and advanced surfactants, are central to Unilever’s $1.2 billion plan to shift to 100% biobased ingredients for its cleaning products by 2030.
Read the full story at Innovation Origins.
For the first time, the Photanol Factory in Groningen is working with special bacteria that convert CO2 into raw materials for bioplastics.
Read the full story from the University of Bath.
The University of Bath is coordinating a major new collaboration with academia and industry to use sustainable chemical technologies to accelerate the UK’s transition to net zero carbon emissions.
Read the full story in Environment + Energy Leader.
The first commercial-scale, renewable bio-based BDO (butanediol) facility in the US will be built as a joint venture between Cargill and HELM. The facility will provide brands the ability to replace fossil-based chemistries with bio-based intermediates and thus reduce their greenhouse gas emissions. The two companies are investing a combined $300 million on the facility, which will be completed and operating in 2024.
Read the full post at Eye on ESG.
The EU Chemicals Strategy for Sustainability Towards a Toxic-Free Environment (CSS) announces the “new long term vision for the EU’s chemical policy’” intended to achieve a toxic-free environment through the “production and use of safe and sustainable chemicals”. In line with the objectives of the EU Green Deal, this ambitious political document is expected to deeply reshape the current EU chemicals regulatory framework for the next decade.